Wood v Glaxo Australia Pty Ltd

Link copied
Case Copied 76 min read

IN THE COURT OF APPEAL

[1993] QCA 114

SUPREME COURT OF QUEENSLAND

C.A. No. 37 of 1992

Brisbane

Before The Chief Justice Mr Justice Davies Mr Justice Ambrose

BETWEEN:

MARY ELLEN WOOD

(Plaintiff) Appellant

- and -

GLAXO AUSTRALIA PTY LTD

(Defendant) Respondent

REASONS FOR JUDGMENT - THE CHIEF JUSTICE

Judgment delivered on 30/03/93.

A substantial outline of the facts and issues with which this appeal is concerned is contained in the reasons which have been prepared by Davies J.A. and Ambrose J. The judge below has also given detailed attention to the evidence. Nothing will be gained by unnecessary repetition. I have concluded that the appeal should be allowed and time extended and I shall attempt to give a sufficient statement of my reasons.

A number of years have now passed since the relevant legislation, the Limitation of Actions Act 1974, and similar legislation in other jurisdictions has been enacted and a body of decisions exists helpfully explaining one or other aspect of it. It is the application of the expounded principles to the particular facts of a case that often continues to present difficulty.

The appellant attributes her physical disability to the myelogram which was performed upon her in 1972 utilising, as she asserts, the oil based agent myodil containing iophendylate. She says that this caused or contributed to her condition of adhesive arachnoiditis. She does not claim to be able to sustain a case in negligence against the medical practitioner, the radiologist, who performed the procedure.

Because of the widespread acceptance of and reliance upon iophendylate by the local and overseas profession in 1972 she apparently appreciates that she would have insuperable difficulty in trying to make out any such case. She attempts to look instead to the local distributor, the respondent company, which is a member of a large worldwide group engaged in the manufacture and sale of pharmaceuticals, including myodil, and she seeks to make out a case of negligence against it.

Although many years went by between her myelogram in 1972 and the date when the writ was issued in 1990, the appellant and her advisors were in the interval far from inactive. They had a difficult case to investigate and the prospects and risks had to be weighed and assessed. They succeeded finally in gathering a good deal of material to support her claim. The question remains whether, in the circumstances which have been established and within the limits of what the legislation permits, they have shown a sufficient case justifying the making of an order for the necessary extension of the limitation period.

Any order for extension would involve the appellant's showing that it was not until after the commencement of the year immediately preceding the issue of the writ in March 1990 that she first had means of knowledge of at least one material fact of a decisive character and that, apart from the effect of the limitation period, there was evidence to establish her right of action. These are…

CaseChat AU logo

Keep reading for free

Create a free CaseChat account to read Wood v Glaxo Australia Pty Ltd and more:

  • Read every judgment in full
  • Ask AI and get answers linked to paragraphs
  • See how each paragraph was cited in later cases
  • Download judgments as PDF or Word
Continue with Google

One click creates your free account or signs you in.

By continuing you agree to the Terms and Privacy Policy.

Details
Case
[1993] QCA 114
Decision Date

CaseChat Overview and Summary

In the case of Wood v Glaxo Australia Pty Ltd, the applicant, Wood, sought an extension of the limitation period to bring an action against the respondent, Glaxo Australia Pty Ltd, for damages arising from a spinal condition sustained after undergoing a myelogram using a substance distributed by the respondent. The Federal Court was tasked with determining whether the existence of a causal relationship between the spinal condition and the substance constituted a material fact of decisive character not within the applicant's knowledge, and whether there was sufficient evidence to establish a right of action against the respondent.

The court considered whether the evidence provided by the applicant was adequate to demonstrate that the respondent's distribution of the substance was negligent or that the respondent failed to adequately warn of the side effects in light of the current state of medical knowledge. The primary focus was on the applicant's ability to ascertain the causal link between the spinal injury and the administered substance, as well as the sufficiency of the evidence presented to establish the respondent's liability.

The court concluded that the existence of a causal relationship between the spinal condition and the substance was indeed a material fact that was not within the applicant's means of knowledge. Given the complexity of the medical evidence and the current state of medical knowledge, the court found that there was sufficient evidence to establish a right of action against the respondent. Consequently, the court granted the applicant's application for an extension of the limitation period, allowing the action to proceed.

The final orders of the court were to grant the application for an extension of the limitation period, permitting the applicant to bring the action against the respondent. The court's decision hinged on the acknowledgment that the applicant could not have reasonably been expected to know the causal relationship and the adequacy of the evidence provided to support the claim of negligence on the part of the respondent.

Orders

Orders of the court

Full text does not contain this section.

Background

Background to the litigation

Full text does not contain this section.

Evidence

Evidence Before The Court

Full text does not contain this section.

Decision

Reasons for decision

Full text does not contain this section.

Ratio Decidendi

Legal Principle Established

Full text does not contain this section.